Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sharma, S; White, D; Imondi, AR; Placke, ME; Vail, DM; Kris, MG
   Development of inhalational agents for oncologic use
   JOURNAL OF CLINICAL ONCOLOGY
   
   S. Sharma et al., "Development of inhalational agents for oncologic use", J CL ONCOL, 19(6), 2001, pp. 1839-1847
2. Tanaka, T; Kaneda, Y; Li, TS; Matsuoka, T; Zempo, N; Esato, K
   Digitonin enhances the anti-tumor effect of cisplatin against methylcholanthrene-induced rat sarcoma cells in vitro
   ANTICANCER RESEARCH
   
   T. Tanaka et al., "Digitonin enhances the anti-tumor effect of cisplatin against methylcholanthrene-induced rat sarcoma cells in vitro", ANTICANC R, 21(1A), 2001, pp. 313-315
3. Saeki, K; Kaneda, Y; Li, TS; Ueda, K; Esato, K
   Relationship between the concentration of CDDP in tumor and tumor size after isolated lung perfusion treatment experimental study on a solitary pulmonary sarcoma model in rats
   JOURNAL OF SURGICAL ONCOLOGY
   
   K. Saeki et al., "Relationship between the concentration of CDDP in tumor and tumor size after isolated lung perfusion treatment experimental study on a solitary pulmonary sarcoma model in rats", J SURG ONC, 75(3), 2000, pp. 193-196
4. Li, TS; Kaneda, Y; Saeki, K; Ueda, K; Zempo, N; Esato, K
   Pharmacokinetic differences between rat tumour and lung tissues following isolated lung perfusion with cisplatin
   EUROPEAN JOURNAL OF CANCER
   
   T.S. Li et al., "Pharmacokinetic differences between rat tumour and lung tissues following isolated lung perfusion with cisplatin", EUR J CANC, 35(13), 1999, pp. 1846-1850
5. Ueda, K; Sugi, K; Li, TS; Saeki, K; Nawata, S; Esato, K
   The long-term evaluation of pulmonary toxicity following isolated lung perfusion with melphalan in the rat
   ANTICANCER RESEARCH
   
   K. Ueda et al., "The long-term evaluation of pulmonary toxicity following isolated lung perfusion with melphalan in the rat", ANTICANC R, 19(1A), 1999, pp. 141-147
6. Hendriks, JMH; Van Schil, PEY; Van Oosterom, AAT; Kuppen, PJK; Van Marck, E; Eyskens, E
   Isolated lung perfusion with melphalan prolongs survival in a rat model ofmetastatic pulmonary adenocarcinoma
   EUROPEAN SURGICAL RESEARCH
   
   J.M.H. Hendriks et al., "Isolated lung perfusion with melphalan prolongs survival in a rat model ofmetastatic pulmonary adenocarcinoma", EUR SURG RE, 31(3), 1999, pp. 267-271
7. Hendriks, JMH; van Schil, PEY; Eyskens, EJM
   Modified technique of isolated left lung perfusion in the rat
   EUROPEAN SURGICAL RESEARCH
   
   J.M.H. Hendriks et al., "Modified technique of isolated left lung perfusion in the rat", EUR SURG RE, 31(1), 1999, pp. 93-96
8. van der Veen, AH; Seynhaeve, ALB; Breurs, J; Nooijen, PTGA; Marquet, RL; Eggermont, AMM
   In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats
   BRITISH JOURNAL OF CANCER
   
   A.H. van der Veen et al., "In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats", BR J CANC, 79(3-4), 1999, pp. 433-439
9. ABOLHODA A; BROOKS A; CHOUDHRY M; KANEDA Y; LIU D; CHENG HM; BURT M
   CHARACTERIZATION OF LOCAL INFLAMMATORY RESPONSE IN AN ISOLATED LUNG PERFUSION MODEL
   Annals of surgical oncology
   
   A. Abolhoda et al., "CHARACTERIZATION OF LOCAL INFLAMMATORY RESPONSE IN AN ISOLATED LUNG PERFUSION MODEL", Annals of surgical oncology, 5(1), 1998, pp. 87-92
10. Hendriks, JMH; Van Schil, PEY
    Isolated lung perfusion for the treatment of pulmonary metastases
    SURGICAL ONCOLOGY-OXFORD
    
    J.M.H. Hendriks e P.E.Y. Van Schil, "Isolated lung perfusion for the treatment of pulmonary metastases", SURG ONCOL, 7(1-2), 1998, pp. 59-63
11. VANDERVEEN AH; EGGERMONT AMM; TENHAGEN TLM
    STEALTH(R) LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOLID TUMOR TREATMENT
    International journal of pharmaceutics
    
    A.H. Vanderveen et al., "STEALTH(R) LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOLID TUMOR TREATMENT", International journal of pharmaceutics, 162(1-2), 1998, pp. 87-94
12. Li, TS; Sugi, K; Ueda, K; Nawata, K; Nawata, S; Esato, K
    Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodulemodel
    ANTICANCER RESEARCH
    
    T.S. Li et al., "Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodulemodel", ANTICANC R, 18(6A), 1998, pp. 4171-4176
13. BERNARD CE; DAHLBY R; HOENER BA
    AN ISOLATED-PERFUSED LUNG MODEL WITH REAL-TIME DATA-COLLECTION AND ANALYSIS OF LUNG-FUNCTION
    Journal of pharmacological and toxicological methods
    
    C.E. Bernard et al., "AN ISOLATED-PERFUSED LUNG MODEL WITH REAL-TIME DATA-COLLECTION AND ANALYSIS OF LUNG-FUNCTION", Journal of pharmacological and toxicological methods, 38(1), 1997, pp. 41-46
14. SASAKI S; YASUDA K; MCCULLY JD; LOCICERO J
    DEVELOPMENT OF AN ISOLATED, PULSATILE BLOOD-PERFUSED RAT LUNG MODEL FOR EVALUATING THE PRESERVED LUNG FUNCTIONS
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    
    S. Sasaki et al., "DEVELOPMENT OF AN ISOLATED, PULSATILE BLOOD-PERFUSED RAT LUNG MODEL FOR EVALUATING THE PRESERVED LUNG FUNCTIONS", SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 27(12), 1997, pp. 1154-1159
15. MURDTER TE; SPERKER B; KIVISTO KT; MCCLELLAN M; FRITZ P; FRIEDEL G; LINDER A; BOSSLET K; TOOMES H; DIERKESMANN R; KROEMER HK
    ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE
    Cancer research
    
    T.E. Murdter et al., "ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE", Cancer research, 57(12), 1997, pp. 2440-2445